The Minnesota Partnership for Biotechnology and Medical Genomics is awarding nearly $5.4 million in state?funded research support to six research teams. This new round of scientific exploration will provide initial support for research on cancer, neurological diseases, heart disease, gastrointestinal conditions and nanotechnology that could impact a range of diseases.
Statement of Dr. George W. Crabtree, Senior Scientist, Associate Division Director and Distinguished Fellow, Materials Sciences Division, Argonne National Laboratory before the Committee on Energy and Natural Resources.
By programming cells with short lengths of synthetic DNA on their surfaces, scientists can control how different cell types bind together to form complex artificial microtissues for potential applications in medicine, and in medical and biological research.
A new study has revealed deep divisions on how nanotechnology should be regulated, with environmental lobby groups seeking a moratorium until products are proven to be safe, and industry proposing that specific guidelines be introduced to supplement existing regulations.